Thomas A. Edwards is Director at ChemoCentryx, Inc. (CCXI). They have made 4 open-market trades across 1 company since 2016, most recently 2022-10-20.
CIK 0001648283
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $304K since 2016, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CCXI | 143,306 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2022-05-31 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CCXI | SELL · 10b5-1 | 2021-03-02 | 2021-03-03 | $70.06 | $77K | -5.0% | -18.8% | -83.4% |
| CCXI | SELL · 10b5-1 | 2021-02-09 | 2021-02-11 | $70.04 | $28K | +8.4% | -6.9% | -83.9% |
| CCXI | SELL | 2021-02-02 | 2021-02-04 | $60.94 | $2.4M | -7.2% | -16.8% | -58.6% |
| CCXI | SELL | 2020-12-24 | 2020-12-29 | $61.27 | $2.4M | +1.8% | -6.7% | -19.1% |
| CCXI | BUY | 2016-05-17 | 2016-05-18 | $4.05 | $203K | +12.3% | -1.0% | -7.3% |
| CCXI | BUY | 2016-05-16 | 2016-05-16 | $4.05 | $101K | +8.9% | +31.3% | +7.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.